Kura Oncology: H.C. Wainwright Reaffirms Buy Recommendation - Inclusion of Komfiziti in National Comprehensive Cancer Network Guidelines Praised

Kura Oncology Inc. (KURA) is a biotechnology company focused on developing precision medicine therapies for cancer treatment. The emphasis is on developing small-molecule drug candidates that specifically target signaling pathways involved in cancer, aiming to provide innovative solutions for patients with high medical needs in hematological malignancies and solid tumors. Recent activities of the company highlight the rapid progression of its pipeline. Core Product and Therapeutic Focus The central product in the late development phase of Kura...